TrialBreast cancer research : BCR2021

Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial.

Kathryn Ottolino-Perry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.